[Quality of life of patients with breast cancer receiving hormonal therapy, depending on age and marital status].
Our study involved 247 patients with histologically verified breast tumors, aged 48-89, who had received hormones - tamoxifen as first-line therapy, exemestan (second-line) for 12 months. FACT-B and FACT-G questionnaires were used to assess quality of life. Worse results were reported in tamoxifen-treated patients older than 60 years. Indices of emotional and social security in the two groups: 60-70 year-olds (10.8+/-0.96% and 14.3+/-1.27% vis-à-vis 14.8+/-1.31% and 15.6+/-1.42%, respectively) and over 70 year-olds (15.2+/-1.46% and 15.8+/-1.48%, respectively). Our evidence suggested that a large-seale complex of effective psychological rehabilitation be given, particularly, to those under 60, married andlor with minors, right from the very beginning of treatment.
Trishikina
E A
EA
Orlova
R V
RV
Roman
L D
LD
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D017533:Marital Status; D008875:Middle Aged; D011788:Quality of Life
D018931:Antineoplastic Agents, Hormonal